Inflammopharmacology,
Journal Year:
2024,
Volume and Issue:
32(6), P. 3943 - 3952
Published: Aug. 11, 2024
The
successful
treatment
of
Alzheimer's
disease
(AD)
is
still
a
big
challenge.
Rivastigmine
one
the
most
used
drugs
for
AD.
short
half-life,
lower
bioavailability,
and
less
concentration
drug
in
brain
after
oral
delivery
are
considered
main
drawbacks
rivastigmine.
To
improve
these
drawbacks,
nanostructure-mediated
has
gained
more
attention.
This
study
investigates
effect
rivastigmine-loaded
optimized
chitosan
nano-particles
(RS-CSNPs)
as
polymeric
nano-carriers
by
different
administration
routes
(oral
intranasal)
on
aluminum
chloride
(AlCl
Journal of Ethnopharmacology,
Journal Year:
2023,
Volume and Issue:
323, P. 117679 - 117679
Published: Dec. 29, 2023
SuanZaoRen
Decoction
(SZRD),
a
famous
herbal
prescription,
and
has
been
widely
proven
to
have
positive
therapeutic
effects
on
insomnia,
depression
Alzheimer's
disease
(AD).
However,
the
anti-AD
molecular
mechanism
of
SZRD
remains
be
further
investigated.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(5), P. 2592 - 2592
Published: Feb. 23, 2024
Leopoldia
comosa
(LC),
popularly
known
as
Muscari
comosum,
spontaneously
grows
in
the
Mediterranean
region
and
its
bulbs
are
used
a
vegetable.
Traditionally,
they
also
to
treat
various
diseases
conditions,
which
has
inspired
study
of
pharmacological
activities
different
parts
LC.
These
studies
revealed
numerous
biological
properties
LC
including
antioxidant,
anti-inflammatory,
anti-diabetes,
anti-obesity,
anti-cancer,
anti-Alzheimer's
disease,
antibacterial,
immune
stimulant.
High
antioxidant
activity
compared
other
non-cultivated
plants,
potential
role
reported
make
an
excellent
candidate
be
developed
plant
against
important
associated
diseases.
The
presence
diverse
class
phytochemicals
(n
=
85),
especially
flavonoids
homoisoflavones,
LC,
imparts
significance
nutraceutical
candidature
plant.
However,
limited
animal
lack
directional
approach
have
further
design
effective
clinical
for
development
current
is
first
attempt
comprehensively
compile
information
regarding
emphasize
targets/markers
targeted
by
activities,
highlight
gaps
propose
possible
bridges
therapeutic
and/or
supplement
Alzheimer s & Dementia,
Journal Year:
2025,
Volume and Issue:
21(1)
Published: Jan. 1, 2025
Abstract
INTRODUCTION
Iron‐mediated
cell
death
(ferroptosis)
is
a
proposed
mechanism
of
Alzheimer's
disease
(AD)
pathology.
While
iron
essential
for
basic
biological
functions,
its
reactivity
generates
oxidants
which
contribute
to
damage
and
death.
METHODS
To
further
resolve
mechanisms
iron‐mediated
toxicity
in
AD,
we
analyzed
post
mortem
human
brain
ApoEFAD
mice.
RESULTS
AD
brains
had
decreased
antioxidant
enzymes,
including
those
mediated
by
glutathione
(GSH).
Subcellular
analyses
showed
greater
oxidative
lower
enzymes
lipid
rafts,
the
site
amyloid
processing,
than
non‐raft
membrane
fraction.
Apolipoprotein
E
ε4
carriers
raft
yield
with
oxidation.
The
hypothesized
role
pathology
was
tested
mice
chelation
deferoxamine,
fibrillar
peroxidation,
together
increased
GSH‐mediated
antioxidants.
DISCUSSION
These
novel
molecular
pathways
highlight
rafts
during
AD.
Highlghts
have
numerous
markers
ferroptosis,
reduced
levels,
storage.
Lipid
cases
enzyme
levels
activity
are
most
severe
apolipoprotein
carriers.
Neuronal
correlated
defense,
signaling
proteins
suggesting
that
neuronal
loss
linked
these
events.
Chelation
early‐onset
familial
model
reduces
peroxidation
amyloid.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(3), P. 1260 - 1260
Published: Jan. 31, 2025
Alzheimer’s
disease
(AD)
is
a
significant
health
challenge
in
the
21st
century.
In
spite
of
approval
many
new
disease-modifying
therapies
for
AD,
clinical
advantages
these
treatments
are
less
certain.
Aim:
This
investigation
was
intended
to
determine
potential
neuroprotective
impact
morin
hydrate
(MH),
zeolite
clinoptilolite
(ZC),
and/or
physical
and
mental
activities
(PhM)
on
an
aluminum
chloride
(AlCl3)-induced
AD
rat
model.
Methods:
Male
Sprague
Dawley
rats
were
randomly
allocated
into
seven
groups.
Group
I
control
group.
Groups
II–VII
treated
with
AlCl3
5
weeks.
III–VII
tested
effects
MH,
ZC,
PhM.
Biochemical,
brain
histopathological,
behavioral
studies
performed.
Results:
PhM,
ZC
combined
therapy
exhibited
effect
demonstrated
by
corrected
catecholamines
tau
β-amyloid
levels,
as
well
antioxidant
anti-ferroptotic
probably
through
Nrf2/HO-1/GPX4
ACSL4
signaling
pathways.
addition,
counteracted
inflammatory
responses
modulating
TLR4/NF-κβ/NLRP3
inflammasome
expression.
Moreover,
groups
showed
maximum
improvement
both
APOE4/LRP1
Wnt3/β-catenin/GSK-3β
expressions.
Conclusion:
research
highlights
MH
plus
PhM
against
AlCl3-induced
via
modulation
Nrf2/HO-1/GPX4,
TLR4/NF-κβ/NLRP3,
APOE4/LRP1,
It
first
point
out
inclusion
ferroptosis-Nrf2/inflammasomes
cross-talk
neuroprotection
mechanism
MH/ZC
AlCl3-mediated
Nutrients,
Journal Year:
2024,
Volume and Issue:
16(4), P. 542 - 542
Published: Feb. 16, 2024
Bulbil
of
yam
(BY)
extract
contains
various
active
compounds
possessing
many
pharmacological
properties.
However,
little
is
known
about
the
effect
and
underlying
mechanism
BY
on
ethanol-induced
liver
damage.
The
present
study
explored
beneficial
potential
hepatotoxicity.
To
evaluate
its
effectiveness,
HepG2
cells
were
pretreated
with
extract.
effectively
rescued
from
ethanol
treatment
through
inhibition
apoptotic
cell
death
as
well
inhibiting
expression
mitogen-activated
protein
kinase
(MAPK)
proteins
stress
inducers.
increased
typical
antioxidants.
Furthermore,
significantly
inhibited
mitochondrial
dysfunction
endoplasmic
reticulum
(ER)
stress,
which
are
major
ROS-inducing
factors.
Finally,
an
protective
effects
damage,
it
activated
Nrf2
translocation
cytosol
to
nucleus,
in
turn
target
oxidative
suppressor
genes.
Collectively,
our
findings
demonstrate
that
has
antioxidative
contributes
establishment
a
strategy
for
alcohol-derived
injuries.
Current Alzheimer Research,
Journal Year:
2024,
Volume and Issue:
21(2), P. 141 - 154
Published: Feb. 1, 2024
Background:
As
individuals
age,
they
may
develop
Alzheimer's
disease
(AD),
which
is
characterized
by
difficulties
in
speech,
memory
loss,
and
other
issues
related
to
neural
function.
Cycloastragenol
an
active
ingredient
of
Astragalus
trojanus
has
been
used
treat
inflammation,
aging,
heart
disease,
cancer.
Objectives:
This
study
aimed
explore
the
potential
therapeutic
benefits
cycloastragenol
rats
with
experimentally
induced
AD.
Moreover,
underlying
molecular
mechanisms
were
also
evaluated
measuring
Nrf2
HO-1,
are
involved
oxidative
stress,
NFκB
TNF-α,
BCL2,
BAX,
caspase-3,
apoptosis.
Methods:
Sprague-Dawley
given
70
mg/kg
aluminum
chloride
intraperitoneally
daily
for
six
weeks
induce
Following
AD
induction,
25
oral
gavage
three
weeks.
Hippocampal
sections
stained
hematoxylin/
eosin
anti-caspase-3
antibodies.
The
Nrf2,
NFκB,
caspase-3
gene
expressions
protein
levels
samples
analyzed.
Results:
significantly
improved
rats'
behavioral
test
performance.
It
strengthened
organization
hippocampus.
performance
hippocampal
structure
rats.
caused
a
marked
decrease
expression
was
associated
increase
HO-1.
Conclusion:
hippocampus
enhanced
outcomes
tests,
decreased
concentration
AChE
brain,
exerted
antioxidant
anti-inflammatory
effects.
Antiapoptotic
effects
noted,
leading
significant
improvements
cognitive
function,
memory,
behavior
treated